Search

The report is presented at a time of growing European debate over the implementation of the Directive, following the European Parliament’s call for a new assessment and the recent conclusions of the

In Spain, nearly one million people were living with dementia in 2025, according to estimates from Alzheimer Europe, with Alzheimer’s disease accounting for between 60% and 70% of cases. Biotechnology

In Spain, around 50,000 people are affected by sepsis each year and approximately 17,000 die, highlighting the significant impact of this medical emergency. Biotechnology is driving the development of

Agriculture is facing increasing pressure on soil and water resources, with more than 60% of human-induced land degradation occurring on agricultural land. Biotechnology innovation has a key role to

The conference programme will address the sector's major challenges, from advanced therapies and artificial intelligence to the bioeconomy and innovation financing. From 29 September to 1 October, the

The European regulatory framework for genetically modified microorganisms (GMMs) is undergoing an update to keep pace with scientific and technological advances. In this context, the European

Around 60% of human infectious diseases originate in animals. Climate change and globalization are reinforcing the need to improve prevention. In this context, biotechnology must be recognized as a

Biotechnology is driving new strategies to combat ALS, including research on the TDP-43 protein, a key target involved in the majority of cases of the disease. Molefy Pharma, an AseBio member company

We have contributed to the Fraunhofer Institute’s technical questionnaire on the Biotech Act II, the European Commission’s public consultation on this forthcoming legislative initiative, and the

In 2024, the activity of biotech companies in Spain generated more than €13.27 billion in income, representing 1.2% of the national GDP. Investment in R&D by the biotechnology sector increased by 13.9

Biotechnology is redefining the approach to multiple sclerosis through new therapeutic tools, a more precise understanding of the underlying immunological mechanisms, and strategies aimed not only at

From AseBio, we organized the panel entitled ‘European Biotechnology Act: an opportunity to consolidate Spain as a hub for biotechnological innovation’, within the framework of the XIX Annual

We welcome the overall regulatory proposal, but believe it requires greater ambition, specificity, and implementation capacity. We advocate for a Biotech Act I that genuinely improves access to

The Bilbao Exhibition Centre will host the next edition of BIOSPAIN from September 29 to October 1. Under the slogan “Bioinnovation that clicks,” the congress will feature a program focused on health

The event, organized by AseBio and the Salamanca City Council, was held this Tuesday at the Congress and Exhibition Center of the Tormes capital. It brought together 120 attendees from 75

According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries in the European region, equivalent to 17.2 cases per 100,000 inhabitants. One of the main challenges

The Spanish Bioindustry Association (AseBio) has organized a conference at the Ministry of Science that brought together leading institutional, political, and industry stakeholders to present a

Although the biotech sector is at the forefront, we still face persistent structural barriers that hinder women’s retention, promotion, and leadership in science and technology. Globally, fewer than

The regulation requires companies to transparently report unsold or discarded products, including quantities, causes, treatment, and prevention measures. For the biotechnology sector, it represents

In Spain, around 1,500 cases of childhood cancer are diagnosed each year (1% of the total), making research more challenging and requiring cooperation among multiple centers, including internationally

Women remain underrepresented in key sectors of the Fourth Industrial Revolution, accounting for only 22% of professionals in artificial intelligence, 28% in engineering, and 40% in computer science